143 related articles for article (PubMed ID: 28449240)
1. Bone morphogenetic protein signalling in pulmonary hypertension: advances and therapeutic implications.
Yang K; Wang J; Lu W
Exp Physiol; 2017 Sep; 102(9):1083-1089. PubMed ID: 28449240
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
Jiramongkolchai P; Owens P; Hong CC
Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
5. BMP signaling in vascular diseases.
Cai J; Pardali E; Sánchez-Duffhues G; ten Dijke P
FEBS Lett; 2012 Jul; 586(14):1993-2002. PubMed ID: 22710160
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the bone morphogenetic protein (BMP) system in human pulmonary arterial smooth muscle cells isolated from a sporadic case of primary pulmonary hypertension: roles of BMP type IB receptor (activin receptor-like kinase-6) in the mitotic action.
Takeda M; Otsuka F; Nakamura K; Inagaki K; Suzuki J; Miura D; Fujio H; Matsubara H; Date H; Ohe T; Makino H
Endocrinology; 2004 Sep; 145(9):4344-54. PubMed ID: 15192043
[TBL] [Abstract][Full Text] [Related]
7. Secreted BMP antagonists and their role in cancer and bone metastases.
Todd GM; Gao Z; Hyvönen M; Brazil DP; Ten Dijke P
Bone; 2020 Aug; 137():115455. PubMed ID: 32473315
[TBL] [Abstract][Full Text] [Related]
8. Targeting BMP signalling in cardiovascular disease and anaemia.
Morrell NW; Bloch DB; ten Dijke P; Goumans MJ; Hata A; Smith J; Yu PB; Bloch KD
Nat Rev Cardiol; 2016 Feb; 13(2):106-20. PubMed ID: 26461965
[TBL] [Abstract][Full Text] [Related]
9. A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor.
Chan MC; Nguyen PH; Davis BN; Ohoka N; Hayashi H; Du K; Lagna G; Hata A
Mol Cell Biol; 2007 Aug; 27(16):5776-89. PubMed ID: 17576816
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
11. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
12. Regulators and effectors of bone morphogenetic protein signalling in the cardiovascular system.
Luo JY; Zhang Y; Wang L; Huang Y
J Physiol; 2015 Jul; 593(14):2995-3011. PubMed ID: 25952563
[TBL] [Abstract][Full Text] [Related]
13. Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells.
Csiszar A; Labinskyy N; Jo H; Ballabh P; Ungvari Z
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H569-77. PubMed ID: 18539760
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (review).
Ye L; Bokobza SM; Jiang WG
Int J Mol Med; 2009 Nov; 24(5):591-7. PubMed ID: 19787192
[TBL] [Abstract][Full Text] [Related]
15. The role of BMPs in endothelial cell function and dysfunction.
Dyer LA; Pi X; Patterson C
Trends Endocrinol Metab; 2014 Sep; 25(9):472-80. PubMed ID: 24908616
[TBL] [Abstract][Full Text] [Related]
16. BMP signalling in skeletal development, disease and repair.
Salazar VS; Gamer LW; Rosen V
Nat Rev Endocrinol; 2016 Apr; 12(4):203-21. PubMed ID: 26893264
[TBL] [Abstract][Full Text] [Related]
17. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1.
Bengtsson L; Schwappacher R; Roth M; Boergermann JH; Hassel S; Knaus P
J Cell Sci; 2009 Apr; 122(Pt 8):1248-57. PubMed ID: 19339557
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in BMP receptor signaling.
Sieber C; Kopf J; Hiepen C; Knaus P
Cytokine Growth Factor Rev; 2009; 20(5-6):343-55. PubMed ID: 19897402
[TBL] [Abstract][Full Text] [Related]
19. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands.
Mazerbourg S; Hsueh AJ
Hum Reprod Update; 2006; 12(4):373-83. PubMed ID: 16603567
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1.
Wu X; Chang MS; Mitsialis SA; Kourembanas S
Circ Res; 2006 Aug; 99(3):240-7. PubMed ID: 16840720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
